Vertex Pharma names chief scientific officer

FRAMINGHAM (09/24/2003) - Vertex Pharmaceuticals Inc. has named Peter Mueller chief scientific officer and senior vice president of drug discovery and innovation. Mueller joins Vertex from Boehringer Ingelheim Pharmaceuticals. Vicki L. Sato, president of Vertex, said in a press release, "The combination of Peter's scientific passion and management expertise represents an ideal phenotype to lead our global research organization and work closely with Vertex's development group to translate great science into clinically meaningful new drugs."

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about VertexVertex Pharmaceuticals

Show Comments
[]